Publications
2005
Direct DNA binding activity of the fanconi anemia D2 protein.Park WH, Margossian S, Horwitz AA, Simons AM, D'Andrea AD, Parvin JD. J Biol Chem 2005 Apr 23;. Published 2005 Apr 23. Pubmed ID: 15849361.
The Fanconi anemia pathway is required for the DNA replication stress response and for the regulation of common fragile site stability.Howlett NG, Taniguchi T, Durkin SG, D'Andrea AD, Glover TW. Mol Cell 2005 Feb 4;17(3):331-9. Published 2005 Mar 1. Pubmed ID: 15661754.
The deubiquitinating enzyme USP1 regulates the Fanconi anemia pathway.Nijman SM, Huang TT, Dirac AM, Brummelkamp TR, Kerkhoven RM, D'Andrea AD, Bernards R. Published 2005 Feb 4. Pubmed ID: 15694335.
Regulated interaction of the Fanconi anemia protein, FANCD2, with chromatin.Montes de Oca R, Andreassen PR, Margossian SP, Gregory RC, Taniguchi T, Wang X, Houghtaling S, Grompe M, D'Andrea AD. Blood 2005 Feb 1;105(3):1003-9. Epub 2004 Sep 28. Published 2005 Feb 1. Pubmed ID: 15454491.
Detection of somatic mosaicism and classification of Fanconi anemia patients by analysis of the FA/BRCA pathway.Soulier J, Leblanc T, Larghero J, Dastot H, Shimamura A, Guardiola P, Esperou H, Ferry C, Jubert C, Feugeas JP, Henri A, Toubert A, Socie G, Baruchel A, Sigaux F, D'Andrea AD, Gluckman E. Published 2005 Feb 1. Pubmed ID: 15383454.
Human Fanconi anemia monoubiquitination pathway promotes homologous DNA repair.Nakanishi K, Yang YG, Pierce AJ, Taniguchi T, Digweed M, D'Andrea AD, Wang ZQ, Jasin M. Proc Natl Acad Sci U S A 2005 Jan 25;102(4):1110-5. Epub 2005 Jan 13. Published 2005 Jan 25. Pubmed ID: 15650050.
2004
ATR couples FANCD2 monoubiquitination to the DNA-damage response.Andreassen PR, D'Andrea AD, Taniguchi T. Genes Dev 2004 Aug 15;18(16):1958-63. Published 2004 Aug 15. Pubmed ID: 15314022.
The interplay of Fanconi anemia proteins in the DNA damage response.Wang X, D'Andrea AD. DNA Repair (Amst) 2004 Aug-Sep;3(8-9):1063-9. Published 2004 Aug-Sep. Pubmed ID: 15279794.
Functional interaction of monoubiquitinated FANCD2 and BRCA2/FANCD1 in chromatin.Wang X, Andreassen PR, D'Andrea AD. Mol Cell Biol 2004 Jul;24(13):5850-62. Published 2004 Jul. Pubmed ID: 15199141.
Association of biallelic BRCA2/FANCD1 mutations with spontaneous chromosomal instability and solid tumors of childhood.Hirsch B, Shimamura A, Moreau L, Baldinger S, Hag-alshiekh M, Bostrom B, Sencer S, D'Andrea AD. Published 2004 Apr 1. Pubmed ID: 14670928.
2003
Knockdown of zebrafish Fancd2 causes developmental abnormalities via p53-dependent apoptosis.Liu TX, Howlett NG, Deng M, Langenau DM, Hsu K, Rhodes J, Kanki JP, D'Andrea AD, Look AT. Dev Cell 2003 Dec;5(6):903-14. Published 2003 Dec. Pubmed ID: 14667412.
Subtyping of Fanconi anemia patients: implications for clinical management.Shimamura A, D'Andrea AD. Blood 2003 Nov 1;102(9):3459. Published 2003 Nov 1. Pubmed ID: 14568911.
The Fanconi road to cancer.D'Andrea AD. Published 2003 Aug 15. Pubmed ID: 12893780.
Menin associates with FANCD2, a protein involved in repair of DNA damage.Jin S, Mao H, Schnepp RW, Sykes SM, Silva AC, D'Andrea AD, Hua X. Cancer Res 2003 Jul 15;63(14):4204-10. Published 2003 Jul 15. Pubmed ID: 12874027.
The Fanconi Anemia/BRCA signaling pathway: disruption in cisplatin-sensitive ovarian cancers.D'Andrea AD. Cell Cycle 2003 Jul-Aug;2(4):290-2. Published 2003 Jul-Aug. Pubmed ID: 12851475.
Genetic reversion in an acute myelogenous leukemia cell line from a Fanconi anemia patient with biallelic mutations in BRCA2.Ikeda H, Matsushita M, Waisfisz Q, Kinoshita A, Oostra AB, Nieuwint AW, De Winter JP, Hoatlin ME, Kawai Y, Sasaki MS, D'Andrea AD, Kawakami Y, Joenje H. Cancer Res 2003 May 15;63(10):2688-94. Published 2003 May 15. Pubmed ID: 12750298.
Disruption of the Fanconi anemia-BRCA pathway in cisplatin-sensitive ovarian tumors.Taniguchi T, Tischkowitz M, Ameziane N, Hodgson SV, Mathew CG, Joenje H, Mok SC, D'Andrea AD. Nat Med 2003 May;9(5):568-74. Epub 2003 Apr 7. Published 2003 May. Pubmed ID: 12692539.
The Fanconi anaemia/BRCA pathway.D'Andrea AD, Grompe M. Nat Rev Cancer 2003 Jan;3(1):23-34. Published 2003 Jan. Pubmed ID: 12509764.
2002
A novel diagnostic screen for defects in the Fanconi anemia pathway.Shimamura A, de Oca RM, Svenson JL, Haining N, Moreau LA, Nathan DG, D'Andrea AD. Blood 2002 Dec 15;100(13):4649-54. Epub 2002 Aug 29. Published 2002 Dec 15. Pubmed ID: 12393398.
Interaction of FANCD2 and NBS1 in the DNA damage response.Nakanishi K, Taniguchi T, Ranganathan V, New HV, Moreau LA, Stotsky M, Mathew CG, Kastan MB, Weaver DT, D'Andrea AD. Nat Cell Biol 2002 Dec;4(12):913-20. Published 2002 Dec. Pubmed ID: 12447395.
Heterogeneous activation of the Fanconi anemia pathway by patient-derived FANCA mutants.Adachi D, Oda T, Yagasaki H, Nakasato K, Taniguchi T, D'Andrea AD, Asano S, Yamashita T. Hum Mol Genet 2002 Dec 1;11(25):3125-34. Published 2002 Dec 1. Pubmed ID: 12444097.
S-phase-specific interaction of the Fanconi anemia protein, FANCD2, with BRCA1 and RAD51.Taniguchi T, Garcia-Higuera I, Andreassen PR, Gregory RC, Grompe M, D'Andrea AD. Blood 2002 Oct 1;100(7):2414-20. Published 2002 Oct 1. Pubmed ID: 12239151.
The Fanconi anemia protein, FANCE, promotes the nuclear accumulation of FANCC.Taniguchi T, D'Andrea AD. Blood 2002 Oct 1;100(7):2457-62. Published 2002 Oct 1. Pubmed ID: 12239156.
Biallelic inactivation of BRCA2 in Fanconi anemia.Howlett NG, Taniguchi T, Olson S, Cox B, Waisfisz Q, De Die-Smulders C, Persky N, Grompe M, Joenje H, Pals G, Ikeda H, Fox EA, D'Andrea AD. Science 2002 Jul 26;297(5581):606-9. Epub 2002 Jun 13. Published 2002 Jul 26. Pubmed ID: 12065746.
Convergence of the fanconi anemia and ataxia telangiectasia signaling pathways.Taniguchi T, Garcia-Higuera I, Xu B, Andreassen PR, Gregory RC, Kim ST, Lane WS, Kastan MB, D'Andrea AD. Cell 2002 May 17;109(4):459-72. Published 2002 May 17. Pubmed ID: 12086603.